These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8341501)

  • 21. Ultrastructural changes in rat eyes with experimental Vogt-Koyanagi-Harada disease.
    Hayakawa K; Ishikawa M; Yamaki K
    Jpn J Ophthalmol; 2004; 48(3):222-7. PubMed ID: 15175913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choroidal neovascularization in long-standing case of Vogt-Koyanagi-Harada disease.
    Inomata H; Minei M; Taniguchi Y; Nishimura F
    Jpn J Ophthalmol; 1983; 27(1):9-26. PubMed ID: 6190031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.
    Sugita S; Sagawa K; Mochizuki M; Shichijo S; Itoh K
    Int Immunol; 1996 May; 8(5):799-803. PubMed ID: 8671669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vogt-Koyanagi-Harada disease].
    Bonnet C; Daudin JB; Monnet D; Brézin A
    J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vogt-Koyanagi-Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options.
    Silpa-Archa S; Silpa-Archa N; Preble JM; Foster CS
    Autoimmun Rev; 2016 Aug; 15(8):809-19. PubMed ID: 27060382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.
    Yamaki K; Gocho K; Hayakawa K; Kondo I; Sakuragi S
    J Immunol; 2000 Dec; 165(12):7323-9. PubMed ID: 11120868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease.
    Kogiso M; Tanouchi Y; Miki S; Mimura Y
    Jpn J Ophthalmol; 1992; 36(1):37-43. PubMed ID: 1635294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vogt-Koyanagi-Harada syndrome--isolation of cloned T cells with specificity for melanocytes and melanoma cells.
    McClellan KA; MacDonald M; Hersey P; Billson FA
    Aust N Z J Ophthalmol; 1989 Nov; 17(4):347-52. PubMed ID: 2624724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome.
    Numaga J; Matsuki K; Tokunaga K; Juji T; Mochizuki M
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):1958-61. PubMed ID: 2055689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA typing in Vogt-Koyanagi-Harada syndrome in North Indian patients.
    Gupta A; Kamal S; Gupta V; Bambery P; Kaura B
    Ocul Immunol Inflamm; 2007; 15(2):89-97. PubMed ID: 17558833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population].
    Zhang M; Qiu C; Hu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):36-40. PubMed ID: 12903490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome.
    Rao NA
    Eye (Lond); 1997; 11 ( Pt 2)():213-6. PubMed ID: 9349415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans.
    Kim MH; Seong MC; Kwak NH; Yoo JS; Huh W; Kim TG; Han H
    Am J Ophthalmol; 2000 Feb; 129(2):173-7. PubMed ID: 10682969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease.
    DiPreta EA; Smith KJ; Williams J; Skelton AH
    J Cutan Med Surg; 2000 Jul; 4(3):156-60. PubMed ID: 11003722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
    Xu M; Wang C; Tian Y; Kijlstra A; Yang P
    Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.
    Gocho K; Kondo I; Yamaki K
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2004-9. PubMed ID: 11481264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
    Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
    Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.
    Egbeto IA; Garelli CJ; Piedra-Mora C; Wong NB; David CN; Robinson NA; Richmond JM
    Front Immunol; 2020; 11():590558. PubMed ID: 33384688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.